Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, controlled trial comparing the safety and effectiveness of
conventional therapy with ecallantide to conventional therapy with placebo.